drugset / Trial / NCT01012882

Efficacy and Safety of Sublingual Immunotherapy (SLIT)

NCT01012882

Phase 3 Unknown 120 enrolled Roxall
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of specific sublingual immunotherapy (SLIT) with allergen extracts in patients suffering from seasonal allergic rhinitis .

Timeline

Start
2016-11
Primary completion
2017-11
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Allergen extract Unknown Other